Is This Beaten-Down Stock a Buy Near Its 52-Week Low?

Iovance's poor first quarter Penny stocks -- companies with shares trading at around $5 or even less apiece -- usually carry above-average risk. However, there may be hidden gems among them: companies with attractive prospects that continue to be ignored by most investors. Identifying those penny stocks with significant latent upside potential and investing in them before they catch fire can lead to life-changing returns. That brings us to Iovance Biotherapeutics (IOVA -5.03%), a small-cap biotech that has ...